Back to search
FDAFDA · Food and drugs·Recall number D-1167-2023

octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Innovus Pharmaceuticals, Inc., Englewood, CO 80112, Made in Jordan, NDC:57483-610-15.

Published September 27, 2023 · Recall initiated: September 1, 2023

Summary

FDA records drug Class II recall D-1167-2023, published September 27, 2023 and initiated September 1, 2023. Recalling firm: AMMAN PHARMACEUTICAL INDUSTRIES; Status: Ongoing; Reported quantity: 30,490 units; Lot: Lot: YM308 EXP:10/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AMMAN PHARMACEUTICAL INDUSTRIES
Distributor
Product was distributed to two (2) direct accounts in RI and CO.
Lot
Lot: YM308 EXP:10/24;
Risk classification
Class II
Area (FDA)
drug
Country
Jordan

Related recalls

Questions about this recall

Was octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Innovus Pharmaceuticals, Inc., Englewood, CO 80112, Made in Jordan, NDC:57483-610-15. recalled?

Yes. FDA published recall D-1167-2023 on September 27, 2023. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter